Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tussnil Tablet may be taken with or without food, but it is better to take it at a fixed time. Take it with food if stomach upset occurs.
Tussnil Tablet is a combination of five medicines: Phenylpropanolamine, Chlorpheniramine, Guaifenesin, Paracetamol / Acetaminophen and Bromhexine. Phenylpropanolamine is a decongestant which narrows the small blood vessels providing relief from congestion or stuffiness in the nose. Chlorpheniramine is an antiallergic which relieves allergy symptoms like runny nose, watery eyes and sneezing. Guaifenesin and Bromhexine help in the removal of mucus (phlegm) from the airways. Paracetamol / Acetaminophen is an analgesic (pain reliever) and antipyretic (fever reducer). It blocks the release of certain chemical messengers in the brain that are responsible for pain and fever.
Taking Phenylpropanolamine+Chlorpheniramine+Guaifenesin+Paracetamol / Acetaminophen+Bromhexine with alcohol can cause liver damage.
WEIGH RISKS VS BENEFITS
Tussnil Tablet may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Tussnil Tablet during lactation. Please consult your doctor.
Tussnil Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Tussnil Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Tussnil Tablet may not be needed in these patients. Please consult your doctor. Use of Tussnil Tablet may cause excessive sleepiness in patients with end stage kidney disease.
Tussnil Tablet should be used with caution in patients with liver disease. Dose adjustment of Tussnil Tablet may be needed. Please consult your doctor. However, the use of Tussnil Tablet is not recommended in patients with severe liver disease and active liver disease.